Documentos relacionados

1. Estrogen therapy in Turner syndrome: does the type, dose and mode of delivery matter?
2. Tenofovir, emtricitabine, lamivudine and dolutegravir concentrations in plasma and urine following drug intake cessation in a randomized controlled directly observed pharmacokinetic trial to aid point-of-care testing.
3. Florfenicol urinary excretion and its potential for treating canine urinary tract infections.
4. Effects of three different calcium preparations on urinary calcium and hydroxyproline excretion in postmenopausal osteoporotic women.
5. A vaginal estradiol softgel capsule, TX-004HR, has negligible to very low systemic absorption of estradiol: Efficacy and pharmacokinetic data review.
6. Use of a rat model for the simultaneous assessment of pharmacokinetic and pharmacodynamic aspects of bisphosphonate treatment: application to the study of intravenous 14C-labeled 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate.
7. Single and multi-dose pharmacology of recombinant and urinary human chorionic gonadotrophin in men.
8. Story behind meldonium-from pharmacology to performance enhancement: a narrative review.
9. Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects.
10. Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine.